MacroGenics preclinical research on MGD006 DART(R) molecule published
MacroGenics announced publication of a nonclinical research paper on MGD006 in Science Translational Medicine. MGD006 is a humanized, Dual-Affinity Re-Targeting (DART®) molecule that recognizes both CD123 and CD3. CD123, the Interleukin-3 receptor alpha chain, is expressed on malignant cells. May 27, 2015